Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlutter Entertainment Regulatory News (FLTR)

Share Price Information for Flutter Entertainment (FLTR)

Share Price is delayed by 15 minutes
Get Live Data
7,800.00    164.00 (2.15%)
Bid:
7,810.00
Ask:
7,830.00
Spread: 20.00 (0.256%)
Market Cap: £13.53b
FLTR Live PriceLast checked at - London Stock Exchange

Intraday Flutter Entertainment Share Chart

Credit Agreement Amendment

15 Mar 2024 14:00

RNS Number : 0992H
Flutter Entertainment PLC
15 March 2024
 

15 March 2024

Flutter Entertainment plc (the "Company")

Credit Agreement Amendment

On March 14, 2024, Flutter Entertainment plc (the "Company") and certain of its subsidiaries entered into the First Incremental Assumption Agreement (the "Assumption Agreement") to the Term Loan A, Term Loan B and Revolving Credit Facility Agreement dated as of November 24, 2023 (as amended, the "Credit Agreement").

After giving effect to the Assumption Agreement, the aggregate principal amount of term B loans outstanding under the Credit Agreement will increase by $514.375 million (the "First Incremental Term B Loans"), which shall be fungible with the existing term B loans outstanding under the Credit Agreement. The First Incremental Term B Loans will:

(i) refinance a corresponding amount of term B loans originally due to mature July 22, 2028 incurred by the Company pursuant to the Term Loan B Agreement dated as of July 29, 2022 with Deutsche Bank AG, New York Branch, acting as the original agent and security agent, and the lenders named therein,

(ii) mature on November 30, 2030,

(iii) bear interest, at the Borrower's option, at a per annum rate equal to either (x) ABR (provided that in no event shall such ABR rate with respect to the First Incremental Term B Loans be less than 1.00% per annum) plus an applicable margin equal to 1.25% (or 1.00% upon the Net First Lien Leverage Ratio decreasing to 2.55:1 or below) or (y) Adjusted Term SOFR (provided that in no event shall such Adjusted Term SOFR rate with respect to the First Incremental Term B Loans be less than 0.50%) plus an applicable margin equal to 2.25% (or 2.00% upon the Net First Lien Leverage Ratio decreasing to 2.55:1 or below), and

(iv) require scheduled amortization payments in quarterly amounts equal to 0.25% of the original principal amount of the First Incremental Term B Loans, payable quarterly, with the balance to be paid at maturity on November 30, 2030.

All other terms of the First Incremental Term B Loans and the Credit Agreement will remain substantially the same except as otherwise amended by the Assumption Agreement.

The foregoing description of the Assumption Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Assumption Agreement, which will be filed with the U.S. Securities and Exchange Commission ("SEC") as Exhibit 10.1 to the Company's Current Report on Form 8-K regarding the Assumption Agreement (the "Current Report"), and is incorporated herein by reference. A copy of the Current Report will be available on the SEC's website at sec.gov and on the SEC Filings page of the Company's website www.flutter.com/investors/sec-filings.

 

Enquiries

Company Secretary: Cosec@flutter.com

Investor Relations: Investor.relations@flutter.com

Press: Corporatemedia@flutter.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRBXGDXBXBDGSU
Date   Source Headline
9th Apr 202611:00 amRNSTransaction in Own Shares
8th Apr 202611:00 amRNSTransaction in Own Shares
7th Apr 202611:00 amRNSTransaction in Own Shares
7th Apr 202610:55 amRNSTransaction in Own Shares
1st Apr 20264:00 pmRNSTotal Voting Rights
1st Apr 202612:45 pmRNSTransaction in Own Shares
31st Mar 20266:25 pmRNSTransaction in Own Shares
30th Mar 202612:30 pmRNSTransaction in Own Shares
27th Mar 202611:00 amRNSTransaction in Own Shares
26th Mar 202611:45 amRNSTransaction in Own Shares
25th Mar 20262:00 pmRNSTransaction in Own Shares
24th Mar 202611:00 amRNSTransaction in Own Shares
23rd Mar 202611:00 amRNSTransaction in Own Shares
20th Mar 202611:00 amRNSTransaction in Own Shares
19th Mar 202611:00 amRNSTransaction in Own Shares
18th Mar 202611:00 amRNSTransaction in Own Shares
17th Mar 202611:00 amRNSTransaction in Own Shares
16th Mar 202611:00 amRNSTransaction in Own Shares
16th Mar 202611:00 amRNSTransaction in Own Shares
13th Mar 20264:00 pmRNSHolding(s) in Company
13th Mar 20262:00 pmRNSDirector/PDMR Shareholding
13th Mar 20262:00 pmRNSDirector/PDMR Shareholding
13th Mar 202611:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSHolding(s) in Company
13th Mar 20267:00 amRNSHolding(s) in Company
11th Mar 202610:55 amRNSLaunch of Fifth Tranche of Share Buyback Program
6th Mar 202611:00 amRNSHolding(s) in Company
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20264:00 pmRNSTotal Voting Rights
27th Feb 20267:05 amRNSPublication of Annual Report and Accounts 2025
27th Feb 20267:00 amRNSQ4 and Fiscal Year 2025 Earnings
19th Feb 20264:00 pmRNSNotice of Q4 and Full Year Results 2025
13th Feb 202611:00 amRNSHolding(s) in Company
12th Feb 202611:00 amRNSHolding(s) in Company
11th Feb 20264:00 pmRNSHolding(s) in Company
11th Feb 202611:00 amRNSHolding(s) in Company
2nd Feb 20264:00 pmRNSTotal Voting Rights
28th Jan 20264:00 pmRNSHolding(s) in Company
28th Jan 202611:00 amRNSHolding(s) in Company
27th Jan 20261:05 pmRNSHolding(s) in Company
27th Jan 20261:00 pmRNSHolding(s) in Company
15th Jan 20264:00 pmRNSHolding(s) in Company
14th Jan 20264:00 pmRNSHolding(s) in Company
14th Jan 202612:05 pmRNSAppointment of Independent Non-Executive Director
5th Jan 20264:00 pmRNSHolding(s) in Company
2nd Jan 20264:00 pmRNSTotal Voting Rights
23rd Dec 20254:00 pmRNSHolding(s) in Company
23rd Dec 20254:00 pmRNSHolding(s) in Company
17th Dec 20254:00 pmRNSHolding(s) in Company
11th Dec 202511:55 amRNSAppointment of Independent Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.